Table 2.

Vanderbilt Specialty Pharmacy Stakeholder Analysis

	Vested Interest(s)	Strategic Priorities
Internal stakeholders
Patients	High-quality, seamless healthcare experience	Use research findings to demonstrate better patient outcomes as a result of integrated care
		Use research findings to continually evaluate and improve VSP patients’ medication access, adherence, and health outcomes
Physician champion	Optimal patient outcomes, reduced staff burden from assistance with utilization management, patient satisfaction	Use research to highlight benefits of integrated specialty pharmacist role in reducing provider and clinic burden and improving medication access, medication adherence and persistence, and patient satisfaction
Clinical pharmacist	Optimal patient outcomes, job security	Use research findings to support expansion of pharmacist integration across the health system
		Use research to support and enhance VSP specialty pharmacists as thought leaders in their fields
Health system	Optimal care delivery, revenue generation	Use research findings to secure access to patients through payer contracts and limited distribution drugs through manufacturers to sustain growth of the specialty pharmacy
External stakeholders
Payers	High quality, cost-effective care; prudent spend of healthcare dollars	Use research findings to demonstrate how integrated pharmacies provide better care quality and continuity, closer monitoring of medication appropriateness and optimization, and lower healthcare costs than external pharmacies
Pharmaceutical industry	Optimal real-world medication utilization and outcomes	Use research findings to evaluate the impact of integrated care on the patient journey and clinical outcomes
Other HSSPs	Recognition as a best practice healthcare delivery model in a climate of continual consolidation and vertical integration	Use research findings to support integrated model as the ideal care model

Abbreviations: HSSP, health-system specialty pharmacy; VSP, Vanderbilt Specialty Pharmacy.